Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Regulation of T Cell Senescence in Health and Diseases.

Created on 06 Jul 2026

Authors

Sewon Mun, Seungho Choi, Jaemin Kim, Jihyun Kim, Yeonseok Chung

Published in

Immune network. Volume 26. Issue 3. Pages e27. Epub Jun 10, 2026.

Abstract

Aging is accompanied by a progressive decline in immune function, a process termed immunosenescence, which affects both innate and adaptive immune compartments. Among these, the adaptive immune system-and particularly T cells-undergoes the most profound functional and phenotypic alterations, critically impairing host defense against infections, cancer, and vaccination responses. The age-associated decline of adaptive immunity is shaped by the divergent senescence pathways of CD4+ helper and CD8+ cytotoxic T cells. While both lineages enter a state of cell-cycle arrest, their distinct immunological roles dictate fundamentally different molecular triggers, metabolic adaptations, and functional outcomes. This review synthesizes these subset-specific differences, highlighting how DNA damage-dependent mechanisms and DNA damage-independent processes drive distinct senescence phenotypes. Furthermore, we discuss how these differences contribute to immune system remodeling during aging and explore emerging therapeutic strategies targeting metabolic and signaling pathways to mitigate T cell senescence.

PMID:
42405213
Bibliographic data and abstract were imported from PubMed on 06 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement